Lipopolysaccharide regulates MMP-9 expression through TLR4/NF-κB signaling in human arterial smooth muscle cells

Matrix metalloproteinases (MMPs) are critical to vascular smooth muscle cell migration in vivo. The dysregulation of MMPs is involved in the pathogenesis of abnormal arterial remodeling, aneurysm formation and atherosclerotic plaque instability. It has been confirmed that lipopolysaccharides (LPS) constitute a strong risk factor for the development of atherosclerosis. In this study, we aimed to determine a potential mechanism of LPS on MMP-9 expression in human arterial smooth muscle cells (HASMCs). RT-PCR analysis was used to detect MMP-9 mRNA expression and western blot analysis was performed to examine MMP-9 protein expression. An electrophoretic mobility shift assay was also employed to determine NF-kappa B binding activity. Results showed that LPS induced MMP-9 m RNA and protein expression in HASMCs in a TLR4-dependent manner. Notably, upon blocking the NF-kappa B binding with pyrrolidine dithiocarbamate, it was demonstrated that the expression of MMP-9 by LPS occurs through TLR4/NF-kappa B pathways. It was concluded that LPS induced MMP-9 expression through the TLR4/NF-kappa B pathway. Thus, the TLR4/NF-kappa B pathway may be involved in the pathogenesis of atherosclerosis.